

[ Tue, Sep 17th 2024
] - WOPRAI

[ Fri, Sep 13th 2024
] - WOPRAI

[ Wed, Aug 28th 2024
] - WOPRAI

[ Wed, Jul 31st 2024
] - WOPRAI

[ Tue, Apr 09th 2024
] - WOPRAI

[ Wed, Mar 06th 2024
] - WOPRAI

[ Tue, Mar 05th 2024
] - WOPRAI

[ Mon, Feb 05th 2024
] - WOPRAI

[ Mon, Dec 11th 2023
] - WOPRAI

[ Wed, Dec 06th 2023
] - WOPRAI

[ Tue, Nov 28th 2023
] - WOPRAI

[ Tue, Aug 08th 2023
] - WOPRAI
[ Tue, Aug 08th 2023
] - WOPRAI

[ Mon, Jul 17th 2023
] - WOPRAI

[ Wed, Jun 07th 2023
] - WOPRAI

[ Tue, May 30th 2023
] - WOPRAI

[ Mon, Mar 06th 2023
] - WOPRAI

[ Tue, Dec 20th 2022
] - WOPRAI

[ Fri, Dec 16th 2022
] - WOPRAI

[ Mon, Dec 12th 2022
] - WOPRAI

[ Tue, Nov 29th 2022
] - WOPRAI

[ Mon, Oct 10th 2022
] - WOPRAI

[ Tue, Jun 21st 2022
] - WOPRAI

[ Thu, Oct 07th 2021
] - WOPRAI
[ Thu, Oct 07th 2021
] - WOPRAI
[ Thu, Oct 07th 2021
] - WOPRAI


[ Fri, Jul 29th 2016
] - WOPRAI

[ Tue, Mar 10th 2015
] - WOPRAI

[ Thu, Jan 31st 2013
] - WOPRAI
Akash Tewari Upgraded (BNTX) to Strong Buy and Increased Target to $150 on, Sep 17th, 2024
Akash Tewari of Jefferies, Upgraded "BioNTech SE" (BNTX) to Strong Buy and Increased Target from $96 to $150 on, Sep 17th, 2024.
Akash has made no other calls on BNTX in the last 4 months.
There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 2 agree with Akash's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jessica Fye of "JP Morgan" Upgraded from Sell to Hold and Increased Target to $125 on, Monday, September 16th, 2024
- Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $85 on, Tuesday, August 6th, 2024
These are the ratings of the 3 analyists that currently disagree with Akash
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $113 on, Monday, September 16th, 2024
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $150 on, Monday, September 16th, 2024
- Emmanuel Papadakis of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $95 on, Wednesday, August 7th, 2024